Document Detail


Propranolol Therapy in 55 Infants with Infantile Hemangioma: Dosage, Duration, Adverse Effects, and Outcome.
MedLine Citation:
PMID:  21995836     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
  Propranolol has recently been reported to be a highly effective treatment for infantile hemangioma (IH) and is emerging as a first-line therapy. This study reports the observations after completed propranolol therapy in 55 patients. Propranolol was administered in a dosage of 2 mg/kg per day with initial monitoring of vital signs. Therapy duration was planned for 4 to 6 months; if there was significant relapse, the period of treatment was extended. The mean age of 55 patients at the beginning of the treatment was 6 months (52.7% <4 mos, 30.9% 4-9 mos, 16.3% >9 mos). Thirteen patients (21.7%) showed a reaction possibly due to the medication, but we did not observe any life-threatening adverse effects. The therapy was interrupted due to temporary aggravation of preexisting bronchial asthma in one child. The initially administered dosage was adjusted to the increase of weight in 21 patients (38.2%), but most did not require a dosage adjustment despite somatic growth. Mean duration of treatment was 6 months; younger patients needed longer treatment periods. Response to treatment was favorable; eight (14.5%) showed total regression and 46 (83.4%) partial regression, and one (1.8%) had no response. Propranolol is an efficacious therapy for severe IH. Risks and complications appear moderate. If indicated, therapy should be initiated early to minimize the extent of residual changes. Young patients show quick and extended benefit. Prospective controlled trails are necessary to observe the effects on a long-term basis.
Authors:
Christine J Schupp; Johann-Baptist Kleber; Patrick Günther; Stefan Holland-Cunz
Related Documents :
21707826 - Analysis of t2 intensity by magnetic resonance imaging of deep gray matter nuclei in mu...
21814776 - Intra-articular injection of hyaluronic acid (mw 1,500-2,000 kda; hyalone) in symptomat...
21815736 - Stereotactic radiosurgery for trigeminal neuralgia: outcomes and complications.
21838756 - Treatment of upper-extremity deep-vein thrombosis.
20831776 - The belgian mira (mabthera in rheumatoid arthritis) registry: clues for the optimizatio...
11291286 - Long-term results of facial nerve function after acoustic neuroma surgery--clinical ben...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-13
Journal Detail:
Title:  Pediatric dermatology     Volume:  -     ISSN:  1525-1470     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8406799     Medline TA:  Pediatr Dermatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 Wiley Periodicals, Inc.
Affiliation:
Division Pediatric Surgery Department of Pediatric Cardiology, University Hospital of Heidelberg, Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Execution time, kinetics, and kinematics of the mae-geri kick: Comparison of national and internatio...
Next Document:  Detecting referral and selection bias by the anonymous linkage of practice, hospital and clinic data...